| 80.360 -1.090 (-1.34%) 03-03 14:35 |
|
| Open: | 80.950 |
| High: | 81.230 |
| Low: | 80.010 |
| Pre. close: | 81.450 |
| Volume: | 683,629 |
| Avg. volume: | 2,165,813 |
| MA (50): | 80.667 |
| MA (200): | 83.504 |
| Year high: | 110.880 |
| Year low: | 76.150 |
| Market cap: | 97,038(M) |
| EPS: | 4.03 |
| PE ratio: | 19.94 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Tue, 03 Mar 2026
Sanofi Wins FDA Nod for Dupixent as First Targeted Treatment for Allergic Fungal Rhinosinusitis - TipRanks
Tue, 03 Mar 2026
Sanofi (SNY) extends Dupixent reach and advances sleeping sickness drug - Stock Titan
Tue, 03 Mar 2026
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Sanofi and Bayer - Yahoo Finance
Tue, 03 Mar 2026
Sanofi’s rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease - WebWire
Mon, 02 Mar 2026
Sanofi turns attention to 2026 FIFA World Cup as official supporter of host city Boston - Medical Marketing and Media
Mon, 02 Mar 2026
Spurned by Sanofi, Orano turns to Roche | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.